- Home
- WBS vs RADX Comparison
WBS vs RADX Comparison
Compare WBS & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBS
- RADX
- Stock Information
- Founded
- WBS 1935
- RADX 2021
- Country
- WBS United States
- RADX Australia
- Employees
- WBS N/A
- RADX N/A
- Industry
- WBS Major Banks
- RADX
- Sector
- WBS Finance
- RADX
- Exchange
- WBS Nasdaq
- RADX NYSE
- Market Cap
- WBS 10.8B
- RADX 11.4B
- IPO Year
- WBS N/A
- RADX N/A
- Fundamental
- Price
- WBS $55.80
- RADX $4.68
- Analyst Decision
- WBS Buy
- RADX
- Analyst Count
- WBS 14
- RADX 0
- Target Price
- WBS $61.29
- RADX N/A
- AVG Volume (30 Days)
- WBS 761.8K
- RADX 35.6K
- Earning Date
- WBS 01-17-2025
- RADX 02-26-2025
- Dividend Yield
- WBS 2.87%
- RADX N/A
- EPS Growth
- WBS N/A
- RADX N/A
- EPS
- WBS 4.37
- RADX N/A
- Revenue
- WBS $2,368,286,000.00
- RADX $1,306,729.00
- Revenue This Year
- WBS N/A
- RADX N/A
- Revenue Next Year
- WBS $6.29
- RADX N/A
- P/E Ratio
- WBS $12.75
- RADX N/A
- Revenue Growth
- WBS N/A
- RADX N/A
- 52 Week Low
- WBS $39.34
- RADX $3.55
- 52 Week High
- WBS $63.99
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- WBS 35.57
- RADX N/A
- Support Level
- WBS $58.31
- RADX N/A
- Resistance Level
- WBS $59.83
- RADX N/A
- Average True Range (ATR)
- WBS 1.40
- RADX 0.00
- MACD
- WBS -0.47
- RADX 0.00
- Stochastic Oscillator
- WBS 4.72
- RADX 0.00
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.